Lobefaro, R., Zattarin, E., Nichetti, F., Prisciandaro, M., Ligorio, F., Brambilla, M., . . . Capri, G. (2020). Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: A 10-year, retrospective analysis. Ther Adv Med Oncol.
استشهاد بنمط شيكاغوLobefaro, Riccardo, et al. "Antitumor Activity and Efficacy of Shorter Versus longer Duration of Anthracycline-taxane Neoadjuvant Chemotherapy in Stage II–III HER2-negative Breast Cancer: A 10-year, Retrospective Analysis." Ther Adv Med Oncol 2020.
MLA استشهادLobefaro, Riccardo, et al. "Antitumor Activity and Efficacy of Shorter Versus longer Duration of Anthracycline-taxane Neoadjuvant Chemotherapy in Stage II–III HER2-negative Breast Cancer: A 10-year, Retrospective Analysis." Ther Adv Med Oncol 2020.